310 related articles for article (PubMed ID: 30178341)
1. Hypoxia-/HIF-1α-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2018; 1072():171-175. PubMed ID: 30178341
[TBL] [Abstract][Full Text] [Related]
2. Fatal Alliance of Hypoxia-/HIF-1α-Driven Microenvironmental Traits Promoting Cancer Progression.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2020; 1232():169-176. PubMed ID: 31893407
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression.
Vaupel P; Mayer A
Adv Exp Med Biol; 2016; 876():177-183. PubMed ID: 26782210
[TBL] [Abstract][Full Text] [Related]
4. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.
Hatfield SM; Kjaergaard J; Lukashev D; Belikoff B; Schreiber TH; Sethumadhavan S; Abbott R; Philbrook P; Thayer M; Shujia D; Rodig S; Kutok JL; Ren J; Ohta A; Podack ER; Karger B; Jackson EK; Sitkovsky M
J Mol Med (Berl); 2014 Dec; 92(12):1283-92. PubMed ID: 25120128
[TBL] [Abstract][Full Text] [Related]
5. Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.
Francis A; Venkatesh GH; Zaarour RF; Zeinelabdin NA; Nawafleh HH; Prasad P; Buart S; Terry S; Chouaib S
Crit Rev Immunol; 2018; 38(6):505-524. PubMed ID: 31002604
[TBL] [Abstract][Full Text] [Related]
6. Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.
Leung E; Cairns RA; Chaudary N; Vellanki RN; Kalliomaki T; Moriyama EH; Mujcic H; Wilson BC; Wouters BG; Hill R; Milosevic M
BMC Cancer; 2017 Jun; 17(1):418. PubMed ID: 28619042
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide.
Barsoum IB; Hamilton TK; Li X; Cotechini T; Miles EA; Siemens DR; Graham CH
Cancer Res; 2011 Dec; 71(24):7433-41. PubMed ID: 22006996
[TBL] [Abstract][Full Text] [Related]
8. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
11. Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.
Vaupel P; Multhoff G
Strahlenther Onkol; 2016 May; 192(5):279-87. PubMed ID: 26961686
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia Compromises Anti-Cancer Immune Responses.
Multhoff G; Vaupel P
Adv Exp Med Biol; 2020; 1232():131-143. PubMed ID: 31893404
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic Justifications of Systemic Therapeutic Oxygenation of Tumors to Weaken the Hypoxia Inducible Factor 1α-Mediated Immunosuppression.
Hatfield S; Veszeleiova K; Steingold J; Sethuraman J; Sitkovsky M
Adv Exp Med Biol; 2019; 1136():113-121. PubMed ID: 31201720
[TBL] [Abstract][Full Text] [Related]
14. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
15. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1α in human glioma stem cells.
Lee DH; Cheul Oh S; Giles AJ; Jung J; Gilbert MR; Park DM
Oncotarget; 2017 Jun; 8(25):40233-40245. PubMed ID: 28410215
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Cytotoxic Response: If the Killer Cells Play the Music, the Microenvironmental Hypoxia Plays the Tune.
Chouaib S
Crit Rev Immunol; 2020; 40(2):157-166. PubMed ID: 32749093
[TBL] [Abstract][Full Text] [Related]
17. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment.
Corzo CA; Condamine T; Lu L; Cotter MJ; Youn JI; Cheng P; Cho HI; Celis E; Quiceno DG; Padhya T; McCaffrey TV; McCaffrey JC; Gabrilovich DI
J Exp Med; 2010 Oct; 207(11):2439-53. PubMed ID: 20876310
[TBL] [Abstract][Full Text] [Related]
18. The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors.
Wouters A; Boeckx C; Vermorken JB; Van den Weyngaert D; Peeters M; Lardon F
Curr Pharm Des; 2013; 19(5):907-17. PubMed ID: 22973959
[TBL] [Abstract][Full Text] [Related]
19. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
